223 related articles for article (PubMed ID: 8572907)
21. Cyclopeptides of Linum usitatissimum.
Picur B; Cebrat M; Zabrocki J; Siemion IZ
J Pept Sci; 2006 Sep; 12(9):569-74. PubMed ID: 16878298
[TBL] [Abstract][Full Text] [Related]
22. Potent cyclic monomeric and dimeric peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion based on the Ile-Leu-Asp-Val tetrapeptide.
Dutta AS; Crowther M; Gormley JJ; Hassall L; Hayward CF; Gellert PR; Kittlety RS; Alcock PJ; Jamieson A; Moores JM; Rees A; Wood LJ; Reilly CF; Haworth D
J Pept Sci; 2000 Jul; 6(7):321-41. PubMed ID: 10946997
[TBL] [Abstract][Full Text] [Related]
23. New analogue of cyclolinopeptide B modified by amphiphilic residue of alpha-hydroxymethylmethionine.
Witkowska R; Donigiewicz A; Zimecki M; Zabrocki J
Acta Biochim Pol; 2004; 51(1):67-72. PubMed ID: 15094826
[TBL] [Abstract][Full Text] [Related]
24. Solid state structural analysis of the cyclooctapeptide cyclo- (Pro1-Pro-Phe-Phe-Ac6c-Ile-D-Ala-Val8).
Saviano M; Isernia C; Rossi F; Di Blasio B; Iacovino R; Mazzeo M; Pedone C; Benedetti E
Biopolymers; 2000 Feb; 53(2):189-99. PubMed ID: 10679623
[TBL] [Abstract][Full Text] [Related]
25. Conformational behaviour of a cyclolinopeptide A analogue: two-dimensional NMR study of cyclo(Pro1-Pro-Phe-Phe-Ac6c-Ile-ala-Val8).
Mazzeo M; Isernia C; Rossi F; Saviano M; Pedone C; Paolillo L; Benedetti E; Pavone V
J Pept Sci; 1995; 1(5):330-40. PubMed ID: 9223012
[TBL] [Abstract][Full Text] [Related]
26. Immunomodulatory activity of G-actin fragments containing a thymopentin-like sequence.
Siemion IZ; Strug I; Wysłouch-Cieszyńska A; Nowak E; Wieczorek Z
Arch Immunol Ther Exp (Warsz); 1997; 45(5-6):419-25. PubMed ID: 9437497
[TBL] [Abstract][Full Text] [Related]
27. Influence of Lys-residue deletion on the immunomodulatory activity of peptides related to immunosuppressive region of lactoferrin.
Słoń JI; Siemion IZ; Zimecki M; Wieczorek Z
Arch Immunol Ther Exp (Warsz); 1995; 43(3-4):211-6. PubMed ID: 8744698
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological activity of cyclolinopeptide A analogues modified with γ(3)-bis(homophenylalanine).
Jędrzejczak K; Hrynczyszyn P; Artym J; Kocięba M; Zimecki M; Zabrocki J; Jankowski S
Eur J Med Chem; 2014 Oct; 86():515-27. PubMed ID: 25203781
[TBL] [Abstract][Full Text] [Related]
29. Analogues of cyclolinopeptide A containing alpha-hydroxymethyl amino acid residues.
Zubrzak P; Banaś A; Kaczmarek K; Leplawy MT; Sochacki M; Kowalski ML; Szkudlińska B; Zabrocki J; Di Lello P; Isernia C; Saviano M; Pedone C; Benedetti E
Biopolymers; 2005; 80(2-3):347-56. PubMed ID: 15614802
[TBL] [Abstract][Full Text] [Related]
30. Potent cyclic peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion. Discovery of compounds like cyclo(MePhe-Leu-Asp-Val-D-Arg-D-Arg) (ZD7349) compatible with depot formulation.
Dutta AS; Gormley JJ; Coath M; Hassall L; Hayward CF; Gellert PR; Kittlety RS; Alcock PJ; Ferguson R; Halterman T; Jamieson A; Moors JA; Moores JM; Rees A; Wood LJ; Reilly CF; Haworth D
J Pept Sci; 2000 Aug; 6(8):398-412. PubMed ID: 10969869
[TBL] [Abstract][Full Text] [Related]
31. Immunosuppressive activity of C-terminal fragments of tachykinins.
Siemion IZ; Kubik A; Zimecki M; Wieczorek Z
Arch Immunol Ther Exp (Warsz); 1994; 42(3):201-3. PubMed ID: 7487353
[TBL] [Abstract][Full Text] [Related]
32. Immunosuppressive activity in the series of cycloamanide peptides from mushrooms.
Wieczorek Z; Siemion IZ; Zimecki M; Bolewska-Pedyczak E; Wieland T
Peptides; 1993; 14(1):1-5. PubMed ID: 8441706
[TBL] [Abstract][Full Text] [Related]
33. Cytokine-inducing activity of a proline-rich polypeptide complex (PRP) from ovine colostrum and its active nonapeptide fragment analogs.
Zabłocka A; Janusz M; Rybka K; Wirkus-Romanowska I; Kupryszewski G; Lisowski J
Eur Cytokine Netw; 2001; 12(3):462-7. PubMed ID: 11566627
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and contractile activities of cyclic thrombin receptor-derived peptide analogues with a Phe-Leu-Leu-Arg motif: importance of the Phe/Arg relative conformation and the primary amino group for activity.
Matsoukas JM; Panagiotopoulos D; Keramida M; Mavromoustakos T; Yamdagni R; Wu Q; Moore GJ; Saifeddine M; Hollenberg MD
J Med Chem; 1996 Aug; 39(18):3585-91. PubMed ID: 8784457
[TBL] [Abstract][Full Text] [Related]
35. The immunosuppressive mini-domain of human lactoferrin.
Siemion IZ; Sloń J; Wieczorek Z
J Pept Sci; 1995; 1(5):295-302. PubMed ID: 9223008
[TBL] [Abstract][Full Text] [Related]
36. Differential patterns of cyclosporine A-induced inhibition of humoral and cellular immune responses to sheep erythrocytes in mice.
Zimecki M; Wieczorek Z
Pol J Pharmacol; 2001; 53(5):495-500. PubMed ID: 11990068
[TBL] [Abstract][Full Text] [Related]
37. Molecular dynamics simulation in vacuo and in solution of cyclolinopeptide A: a conformational study.
Saviano M; Aida M; Corongiu G
Biopolymers; 1991 Jul; 31(8):1017-24. PubMed ID: 1782353
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological activity of NK-1 selective, N-backbone cyclic analogs of the C-terminal hexapeptide of substance P.
Byk G; Halle D; Zeltser I; Bitan G; Selinger Z; Gilon C
J Med Chem; 1996 Aug; 39(16):3174-8. PubMed ID: 8759639
[TBL] [Abstract][Full Text] [Related]
39. Effect of lactoferrin on the methotrexate-induced suppression of the cellular and humoral immune response in mice.
Artym J; Zimecki M; Kruzel ML
Anticancer Res; 2004; 24(6):3831-6. PubMed ID: 15736418
[TBL] [Abstract][Full Text] [Related]
40. Ion binding of cyclolinopeptide A: an NMR and CD conformational study.
Tancredi T; Benedetti E; Grimaldi M; Pedone C; Rossi F; Saviano M; Temussi PA; Zanotti G
Biopolymers; 1991 May; 31(6):761-7. PubMed ID: 1932572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
